Skip to content

CROI: Nearly one in fifty European patients may have suffered an opportunistic infection above the expected CD4 count

CROI: Rapid response predicts success in HIV/HCV coinfected patients

CROI: AZT, 3TC and FTC achieve good concentrations in the female genital tract; good candidates for PrEP?

News from the Thirteenth Conference on Retroviruses and Opportunistic Infections

Bristol Myers Squibb announces voluntary licenses for atazanavir in India and South Africa

CROI: Cotrimoxazole prophylaxis reduces adverse birth outcomes in Zambian women with HIV

CROI: Male circumcision reduces risk of transmission of HIV and some STIs to female partners

CROI: Two studies show single-dose nevirapine prevents HIV transmission in consecutive pregnancies

CROI: Abacavir gene testing reveals high levels of hypersensitivity mutation